Clinical Trials on Emphysème sous-cutané
Total 516 results
-
Kamada, Ltd.Syneos HealthRecruitingAlpha 1-Antitrypsin DeficiencyUnited Kingdom, Sweden, Ireland, Netherlands, Belgium, Finland
-
Alpha-1 FoundationRecruiting
-
CSL BehringActive, not recruitingAlpha-1 Antitrypsin DeficiencyFrance
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
Laboratoire français de Fractionnement et de BiotechnologiesCompletedAlpha 1-Antitrypsin Deficiency
-
Mesoblast, Inc.CompletedPulmonary Disease, Chronic Obstructive | Pulmonary Emphysema | Chronic BronchitisUnited States
-
Baxalta now part of ShireCompletedAlpha 1-Antitrypsin DeficiencyNew Zealand, Australia
-
Baxalta now part of ShireBaxter Healthcare, Ltd. (New Zealand), Baxter Healthcare Pty. Ltd. (Australia)CompletedAlpha 1-Antitrypsin DeficiencyAustralia, New Zealand
-
Medical University of South CarolinaAlpha-1 FoundationCompleted
-
National Jewish HealthMedical University of South CarolinaUnknownAlpha 1-Antitrypsin DeficiencyUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
Biocerna LLCCompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
Medical University of South CarolinaNational Center for Research Resources (NCRR); Alpha-1 FoundationCompletedAlpha-1 Antitrypsin DeficiencyUnited States
-
Grifols Therapeutics LLCCompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
Grifols Therapeutics LLCCompletedAlpha 1-Antitrypsin DeficiencyUnited States, United Kingdom
-
University of FloridaAlpha-1 Foundation; Brantly, Mark L., M.D.CompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
Aeris TherapeuticsTerminatedLung Diseases | Pulmonary Emphysema | Chronic Obstructive Pulmonary Disease(COPD)Israel
-
SunovionCompletedChronic Obstructive Pulmonary Disease | Emphysema | BronchitisUnited States
-
National Center for Research Resources (NCRR)University of PittsburghTerminatedAlpha 1-Antitrypsin DeficiencyUnited States
-
Adverum Biotechnologies, Inc.CompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
United TherapeuticsTerminatedPulmonary Hypertension | Interstitial Lung Disease | Combined Pulmonary Fibrosis and EmphysemaUnited States, Puerto Rico
-
Inhibrx, Inc.CompletedAlpha-1 Antitrypsin Deficiency | AATDUnited States, New Zealand, United Kingdom
-
Coram Clinical TrialsCompletedAlpha-1 Anti-trypsin DeficiencyUnited States
-
KU LeuvenChiesi Farmaceutici S.p.A.UnknownEmphysema | COPD | Small Airway DiseaseBelgium
-
Servier Bio-Innovation LLCInstitut de Recherches Internationales ServierRecruitingIDH1-mutant CholangiocarcinomaUnited States, United Kingdom
-
Didem Sakaryali UyarCompletedProbiotics | Tooth Decay | Streptococcus MutansTurkey
-
Arrowhead PharmaceuticalsActive, not recruitingAlpha 1-Antitrypsin DeficiencyAustria, Germany, United Kingdom
-
Ferrer Internacional S.A.AvailablePulmonary Hypertension | Interstitial Lung Disease | Combined Pulmonary Fibrosis and Emphysema
-
Dicerna Pharmaceuticals, Inc.WithdrawnAlpha 1-Antitrypsin DeficiencyNew Zealand
-
Mereo BioPharmaSyneos HealthCompletedEmphysema | Alpha 1-Antitrypsin Deficiency | COPDUnited Kingdom, Belgium, United States, Denmark, Canada, Sweden, Poland, Spain
-
University of Massachusetts, WorcesterNational Heart, Lung, and Blood Institute (NHLBI); University of Florida; National... and other collaboratorsCompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
Kura Oncology, Inc.CompletedThyroid Cancer | Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | HRAS Mutant Tumor | Other Squamous Cell Carcinoma (SCC) With HRAS Mutant TumorSpain, United States, Korea, Republic of, France, Belgium, Germany, Greece, Italy, Netherlands, United Kingdom
-
United TherapeuticsCompletedPulmonary Hypertension | Interstitial Lung Disease | Combined Pulmonary Fibrosis and EmphysemaUnited States, Puerto Rico
-
Applied Genetic Technologies CorpNational Heart, Lung, and Blood Institute (NHLBI)CompletedAlpha-1 Antitrypsin DeficiencyUnited States, Ireland
-
University Hospital, RouenUnknownPulmonary Emphysema | Pulmonary DiseaseFrance
-
Thomayer University HospitalMasaryk UniversityRecruiting
-
Grifols Therapeutics LLCRecruiting
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI); Alpha-1 FoundationActive, not recruitingAlpha 1-Antitrypsin Deficiency | Genetic DiseaseUnited States
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedEmphysema | HIV | Chronic Obstructive Pulmonary Disease (COPD)United States
-
Vertex Pharmaceuticals IncorporatedCompletedAlpha1-Antitrypsin DeficiencyUnited States, Germany, Canada, Ireland, Sweden, United Kingdom
-
Grifols Therapeutics LLCGrifols Japan K.K.Completed
-
Baxalta now part of ShireCompletedAlpha1-antitrypsin DeficiencyUnited States, Canada
-
Baxalta now part of ShireTerminated
-
University of Alabama at BirminghamNational Institutes of Health (NIH); Mereo BioPharmaCompletedEmphysema or COPD | Alpha-1 Antitrypsin Deficiency (AATD) | Pi*ZZ, Pi*SZ, Pi*Null, Another Rare Phenotype/Genotype Known to be Associated With Either Low or Functionally Impaired AAT Including F or I MutationsUnited States
-
University of FloridaAlpha-1 FoundationEnrolling by invitation
-
Grifols Therapeutics LLCGrifols Japan K.K.CompletedAlpha1-Antitrypsin DeficiencyJapan
-
Baxalta now part of ShireArriva Pharmaceuticals, Inc.CompletedAlpha1-antitrypsin DeficiencyUnited States
-
University of California, Los AngeleseResearch Technology (eRT)CompletedPulmonary Disease, Chronic Obstructive | Pulmonary Emphysema | COPD | Bronchitis, Chronic | Chronic Obstructive Lung DiseaseUnited States
-
Federal University of São PauloCompletedPulmonary Disease, Chronic Obstructive | Pulmonary Emphysema | Chronic BronchitisBrazil
-
Baxalta now part of ShireArriva Pharmaceuticals, Inc.CompletedAlpha1-antitrypsin DeficiencyUnited States